Showing results (111-120 of 229) with videos related to
Sort By:
Pageof 23
NPJ Digital Medicine|May 18, 2026
Prospective deployment of AI-based risk stratification to enable expedited mammography workflow in a safety-net settingMaggie Chung, Eric Davis, Heather Greenwood, et al.Leukemia & Lymphoma|August 10, 2017
Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphomaBei Hu, Anas Younes, Jason R Westin, et al.Science Signaling|December 14, 2017
C-reactive protein promotes bone destruction in human myeloma through the CD32-p38 MAPK-Twist axisJing Yang, Zhiqiang Liu, Huan Liu, et al.Cell Reports|August 17, 2022
Multiregional single-cell proteogenomic analysis of ccRCC reveals cytokine drivers of intratumor spatial heterogeneityNatalia Miheecheva, Ekaterina Postovalova, Yang Lyu, et al.British Journal of Haematology|October 15, 2013
Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphomaYasuhiro Oki, Jason R Westin, Francisco Vega, et al.Radiation Oncology (London, England)|September 27, 2015
Incidence and predictors of Lhermitte's sign among patients receiving mediastinal radiation for lymphomaBassem Youssef, JoAnn Shank, Jay P Reddy, et al.Blood|May 13, 2004
Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression responseAndreas Rosenwald, Eric Y Chuang, R Eric Davis, et al.Journal of Cell Science|August 6, 2009
Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actinGreg P Coffey, Ranjani Rajapaksa, Raymond Liu, et al.Clinical Lymphoma, Myeloma & Leukemia|January 2, 2013
Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trialJason R Westin, Michael A Thompson, Vince D Cataldo, et al.Cancer Discovery|February 5, 2021
Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental SignaturesNikita Kotlov, Alexander Bagaev, Maria V Revuelta, et al.Pageof 23